Species-Specific Difference in Antimicrobial Susceptibility Among Viridans Group Streptococci

被引:38
作者
Chun, Sejong [1 ]
Huh, Hee Jae [1 ]
Lee, Nam Yong [1 ]
机构
[1] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Lab Med & Genet, Seoul 135710, South Korea
关键词
Viridans streptococci; Penicillin; Resistance; Microbial; IN-VITRO ACTIVITIES; PENICILLIN-RESISTANT; HEMOLYTIC STREPTOCOCCI; NEUTROPENIC PATIENTS; PNEUMONIAE; IDENTIFICATION; ANTIBIOTICS; INFECTIONS; BACTEREMIA; CHILDREN;
D O I
10.3343/alm.2015.35.2.205
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Background: Viridans group streptococci (VGS) are both commensal microbes and potential pathogens. Increasing resistance to penicillin in VGS is an ongoing issue in the clinical environment. We investigated the difference in susceptibility and resistance to penicillin among various VGS species. Methods: In total 1,448 VGS isolated from various clinical specimens were analyzed over a two-yr period. Identification and antimicrobial susceptibility test was performed by the automated VITEK 2 system (bioMerieux, France) or the Micro Scan MICroSTREP system (Siemens, Germany). Results: Among the 1,448 isolates, 412 were isolated from blood (28.4%). Streptococcus mitis group was the most frequently isolated (589 isolates, 40.7%), followed by the Streptococcus anginosus group (290 isolates, 20.0%), Streptococcus sanguinis group (179 isolates, 12.4%) and Streptococcus salivarius group (57 isolates, 3.9%). In total, 314 isolates could not be identified up to the species level. The overall non-susceptibility to penicillin was observed to be 40.0% (resistant, 11.2% and intermediately resistant, 28.8%) with uneven distribution among groups; 40.2% in Streptococcus sanguinis group (resistant, 5.0% and intermediately resistant, 35.2%), 60.3% in Streptococcus mitis group (resistant, 20.9% and intermediately resistant, 39.4%), 78.9% in Streptococcus salivarius group (resistant, 8.8% and intermediately resistant, 70.1%), and 6.2% in Streptococcus anginosus group (resistant, 1.7% and intermediately resistant, 4.5%). Conclusions: Antimicrobial resistance patterns towards penicillin show differences among various VGS; this should be considered while devising an effective antimicrobial treatment against VGS.
引用
收藏
页码:205 / 211
页数:7
相关论文
共 23 条
[1]   IN-VITRO ACTIVITIES OF 22-BETA-LACTAM ANTIBIOTICS AGAINST PENICILLIN-RESISTANT AND PENICILLIN-SUSCEPTIBLE VIRIDANS GROUP STREPTOCOCCI ISOLATED FROM BLOOD [J].
ALCAIDE, F ;
LINARES, J ;
PALLARES, R ;
CARRATALA, J ;
BENITEZ, MA ;
GUDIOL, F ;
MARTIN, R .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1995, 39 (10) :2243-2247
[2]   A European study on the relationship between antimicrobial use and antimicrobial resistance [J].
Bronzwaer, SLAM ;
Cars, O ;
Buchholz, U ;
Mölstad, S ;
Goettsch, W ;
Veldhuijzen, IK ;
Kool, JL ;
Sprenger, MJW ;
Degener, JE .
EMERGING INFECTIOUS DISEASES, 2002, 8 (03) :278-282
[3]   Viridans group streptococci: a reservoir of resistant bacteria in oral cavities [J].
Bryskier, A .
CLINICAL MICROBIOLOGY AND INFECTION, 2002, 8 (02) :65-69
[4]  
Cho EunHae Cho EunHae, 2003, Korean Journal of Laboratory Medicine, V23, P246
[5]   Antimicrobial resistance in viridans group streptococci among patients with and without the diagnosis of cancer in the USA, Canada and Latin America [J].
Diekema, DJ ;
Beach, ML ;
Pfaller, MA ;
Jones, RN .
CLINICAL MICROBIOLOGY AND INFECTION, 2001, 7 (03) :152-157
[6]   It's Not Easy Being Green: the Viridans Group Streptococci, with a Focus on Pediatric Clinical Manifestations [J].
Doern, Christopher D. ;
Burnham, Carey-Ann D. .
JOURNAL OF CLINICAL MICROBIOLOGY, 2010, 48 (11) :3829-3835
[7]   Antimicrobial resistance with Streptococcus pneumoniae in the United States, 1997-98 [J].
Doern, GV ;
Brueggemann, AB ;
Huynh, H ;
Wingert, E ;
Rhomberg, P .
EMERGING INFECTIOUS DISEASES, 1999, 5 (06) :757-765
[8]   EVOLUTION OF PENICILLIN RESISTANCE IN STREPTOCOCCUS-PNEUMONIAE - THE ROLE OF STREPTOCOCCUS-MITIS IN THE FORMATION OF A LOW-AFFINITY PBP2B IN STREPTOCOCCUS-PNEUMONIAE [J].
DOWSON, CG ;
COFFEY, TJ ;
KELL, C ;
WHILEY, RA .
MOLECULAR MICROBIOLOGY, 1993, 9 (03) :635-643
[9]   What happened to the streptococci: Overview of taxonomic and nomenclature changes [J].
Facklam, R .
CLINICAL MICROBIOLOGY REVIEWS, 2002, 15 (04) :613-+
[10]   MULTIPLY RESISTANT VIRIDANS STREPTOCOCCI - SUSCEPTIBILITY TO BETA-LACTAM ANTIBIOTICS AND COMPARISON OF PENICILLIN-BINDING PROTEIN-PATTERNS [J].
FARBER, BF ;
ELIOPOULOS, GM ;
WARD, JI ;
RUOFF, KL ;
SYRIOPOULOU, V ;
MOELLERING, RC .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1983, 24 (05) :702-705